LAS CRUCES, NEW MEXICO / ACCESS Newswire / April 29, 2025 / As newly appointed CMS Administrator Dr. Mehmet Oz renews focus ...

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...

New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

LOS ANGELES, CA / ACCESS Newswire / April 29, 2025 / In the world of spine surgery, few conditions remain as misunderstood and underdiagnosed as Bertolotti Syndrome - a complex, often-overlooked cause ...

Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based ...

LUND, SWEDEN / ACCESS Newswire / April 29, 2025 / The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to re-elect the Board members Natalie ...

Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in ...

SAN JUAN CAPISTRANO, CALIFORNIA / ACCESS Newswire / April 29, 2025 / Alter Behavioral Health announces the grand opening of its new Luxury Residential Crisis Center in San Juan Capistrano. This ...

New offering empowers hospitals to enhance clinical excellence, streamline operations, and helps secure sustainable financial growth without disrupting existing clinician employment models. BRENTWOOD, ...

Atopic dermatitis (AD) is a very common, heterogeneous and debilitating disease with a need for new treatment optionsCAN10 targets several pathways relevant for AD but distinct from current treatments ...

Collaboration combines Scipher's unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN's proprietary Comprehensive Pathway Analysis (CPA) ...